Cross-talking between autophagy and viral infection in mammalian cells

Autophagy is a cellular process in degradation of long-lived proteins and organelles in the cytosol for maintaining cellular homeostasis,which has been linked to a wide range of human health and disease states,including viral infection.The viral infected cells exhibit a compli-cated cross-talking between autophagy and virus.It has been shown that autophagy interacts with both adaptive and innate immunity.For adaptive immunity,viral antigens can be processed in autophagosomes by acidic proteases before major histocompatibility complex(MHC)class II presentation.For innate immunity,autophagy may assist in the delivery of viral nucleic acids to endosomal TLRs and also functions as a part of the TLR-or-PKR-downstream responses.Autophagy was also reported to suppress the magnitude of host innate antiviral immunity in certain cases.On the other hand,viruses has evolved many strategies to combat or utilize the host autophagy for their own benefit.In this review we discussed recent advances toward clarifying the cross-talking between autophagy and viral infection in mammalian cells.

Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk:a single-center study

Low-density lipoprotein cholesterol(LDL-C)is an independent risk factor for atherosclerotic cardiovascular disease(ASCVD).Even after lipid-lowering therapy(LLT)with statins or statin–ezetimibe,a large proportion of patients at very high risk still do not reach the LDL-C targets(<1.4 mmol/L and≥50%reduction).[1,2]Proprotein convertase subtilisin/kexin type 9 inhibitor(PCSK9i)is recommended for patients at high or very high cardiovascular risk inwhom LDL-C reduction is not adequate with statin therapy or in those with statin intolerance.Limited data are available regarding the use of PCSK9i in China.